Any feedback?
Literature summary extracted from
- Multi-functional property of rat liver mitochondrial cytochrome P-450 (1991), J. Biochem., 109, 389-393.
Inhibitors
| EC Number | Inhibitors | Comment | Organism | Structure |
|---|---|---|---|---|
| 1.14.15.15 | 1alpha-hydroxyvitamin D3 | competes with 5beta-cholestane-3alpha,7alpha,12alpha-triol | Rattus norvegicus |  |
| 1.14.15.15 | 5beta-cholestane-3alpha,7alpha,12alpha-triol | competes with 1alpha-hydroxyvitamin D3 | Rattus norvegicus | |
| 1.14.15.15 | N-bromosuccinimide | 50% loss of activity at 0.1 mM | Rattus norvegicus | |
Localization
| EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
|---|---|---|---|---|---|
| 1.14.15.15 | mitochondrion | - |
Rattus norvegicus | 5739 | - |
Organism
| EC Number | Organism | UniProt | Comment | Textmining |
|---|---|---|---|---|
| 1.14.15.15 | Rattus norvegicus | - |
- |
- |
Purification (Commentary)
| EC Number | Purification (Comment) | Organism |
|---|---|---|
| 1.14.15.15 | - |
Rattus norvegicus |
Source Tissue
| EC Number | Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|---|
| 1.14.15.15 | liver | - |
Rattus norvegicus | - |
Specific Activity [micromol/min/mg]
| EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
|---|---|---|---|---|
| 1.14.15.15 | 0.00233 | - |
1alpha-hydroxyvitamin D3 as substrate | Rattus norvegicus |
| 1.14.15.15 | 0.114 | - |
5beta-cholestane-3alpha,7alpha,12alpha-triol as substrate | Rattus norvegicus |
Substrates and Products (Substrate)
| EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|---|
| 1.14.15.15 | 1alpha-hydroxyvitamin D3 + reduced adrenodoxin + O2 | 25-hydroxylation | Rattus norvegicus | 1alpha,25-dihydroxyvitamin D3 + oxidized adrenodoxin + H2O | - |
? | |
| 1.14.15.15 | 5beta-cholestane-3alpha,7alpha,12alpha-triol + reduced adrenodoxin + O2 | - |
Rattus norvegicus | 5beta-cholestane-3alpha,7alpha,12alpha,27-tetrol + oxidized adrenodoxin + H2O | - |
? | |
| 1.14.15.15 | 5beta-cholestane-3alpha,7alpha-diol + reduced adrenodoxin + O2 | - |
Rattus norvegicus | ? | - |
? | |
Temperature Stability [°C]
| EC Number | Temperature Stability Minimum [°C] | Temperature Stability Maximum [°C] | Comment | Organism |
|---|---|---|---|---|
| 1.14.15.15 | 45 | - |
90% loss of activity after 2 min | Rattus norvegicus |
Turnover Number [1/s]
| EC Number | Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
|---|---|---|---|---|---|---|
| 1.14.15.15 | 0.0233 | - |
1alpha-hydroxyvitamin D3 | - |
Rattus norvegicus | |
| 1.14.15.15 | 0.217 | - |
5beta-cholestane-3alpha,7alpha-diol | - |
Rattus norvegicus | |
| 1.14.15.15 | 0.6 | - |
5beta-cholestane-3alpha,7alpha,12alpha-triol | - |
Rattus norvegicus | |
Ki Value [mM]
| EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
|---|---|---|---|---|---|---|
| 1.14.15.15 | 0.004 | - |
5beta-cholestane-3alpha,7alpha,12alpha-triol | - |
Rattus norvegicus | |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
